Stock listing

DYN Stock Price, News, Filings & Events — Dyne Therapeutics, Inc.

Selected listing: DYN · NASDAQ · USD · US

This page tracks Dyne Therapeutics, Inc.'s DYN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DYN:NASDAQ. DYN:NASDAQ is the stock-level entry point for investors researching Dyne Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Dyne Therapeutics, Inc. (ticker: DYN) is a publicly traded company based in the United States, with a market capitalization of approximately $4.49 billion. The company focuses on developing innovative therapies for serious diseases, leveraging its proprietary technology platform. Dyne Therapeutics aims to address unmet medical needs through its research and development efforts.

DYN:NASDAQUSDUSUpdated September 11, 2026
Dyne Therapeutics, Inc. logo
Ticker
DYN:NASDAQ
Asset type
Stock
Market cap
$3.40B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

Dyne Therapeutics, Inc. DYN:NASDAQ stock context

This page tracks Dyne Therapeutics, Inc.'s DYN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DYN:NASDAQ. DYN:NASDAQ is the stock-level entry point for investors researching Dyne Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Dyne Therapeutics, Inc. (ticker: DYN) is a publicly traded company based in the United States, with a market capitalization of approximately $4.49 billion. The company focuses on developing innovative therapies for serious diseases, leveraging its proprietary technology platform. Dyne Therapeutics aims to address unmet medical needs through its research and development efforts.

Latest news from Dyne Therapeutics, Inc.

All Dyne Therapeutics, Inc. news →

Research Dyne Therapeutics, Inc.

Alternate listings